newsfilter
← Latest News
GlobeNewswire·

Paratek Pharmaceuticals Announces Inclusion of NUZYRA® (omadacycline) in China's National Reimbursement Drug List (NRDL)

BOSTON, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) today announced that China's National Healthcare Security Administration (NHSA) has added the intravenous (IV) formulation of